Prev:RASSF1A independence and early galectin‐1 upregulation in PIK3CA‐induced hepatocarcinogenesis: new therapeutic venues(A21020-4.5)
Next:Rational Design of Ultrabright NIR-II Nanofluorophores with Enhanced Photothermal Conversion Efficiency for Targeted Chemodynamic-Hypothermal Photothermal Therapy of Hepatocellular Carcinoma.(KTA1001-10.2)